AAPM

Scilex Holding Company Announces Acceptance of Abstract for Poster and Oral Presentation at the Annual Meeting of the American Academy of Pain Medicine (AAPM)

Retrieved on: 
Tuesday, February 27, 2024

Titled: Decreased Opioid Utilization with Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch: A Retrospective Claims Analysis (First author: Srinivas Nalamachu, M.D.).

Key Points: 
  • Titled: Decreased Opioid Utilization with Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch: A Retrospective Claims Analysis (First author: Srinivas Nalamachu, M.D.).
  • In addition, patients treated with ZTlido® had a more significant reduction in opioid dose relative to a generic lidocaine 5% patch.
  • Regardless of the type of neuropathic pain, ZTlido® was associated with a greater opioid-sparing effect than a generic lidocaine 5% patch.
  • As a result, improved adhesion for ZTlido® is likely contributing to more optimal pain management and enable reduction/discontinuation of opioid dose.

Delinea Receives United States Patent for Delegated Machine Credentials

Retrieved on: 
Wednesday, December 6, 2023

SAN FRANCISCO, Dec. 6, 2023 /PRNewswire/ -- Delinea, a leading provider of solutions that seamlessly extend Privileged Access Management (PAM), today announced that it has been awarded a patent for Delegated Machine Credentials (DMC), a capability within Server PAM, its solution that provides privileged access to and authorization for servers. DMC reduces risk and empowers automation for DevOps and DevSecOps teams building applications that require privileged access to and for workloads on cloud and on-premise infrastructure. By delegating entitlements of a specific machine to the workloads running on it, there is a significant reduction of service accounts needed, thus reducing the attack surface and improving the agility of development teams.

Key Points: 
  • For organizations looking for an alternative to a vault-centric approach already addressed by Delinea DevOps Secrets Vault , customers can streamline privilege controls on their infrastructure while providing secure and efficient machine access using Delegated Machine Credentials in the Server PAM solution.
  • Using a client-based approach and leveraging a cloud-first architecture, the Delegated Machine Credentials capability solves a headache for DevOps teams by federating access for machine identities.
  • "We're very pleased to see Delinea's innovation recognized with this new US patent for Delegated Machine Credentials," said David McNeely, Chief Technology Officer at Delinea.
  • For more information about US Patent 11,706,209, visit https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/11706209
    For a free trial of Delegated Machine Credentials within Delinea Server PAM, visit https://delinea.com/products/server-pam .

Guidance Statement for Mental Health Symptoms of Long COVID Announced by the American Academy of Physical Medicine and Rehabilitation

Retrieved on: 
Wednesday, November 8, 2023

Long COVID can cause new mental health symptoms, worsen existing mental health conditions, or mimic other LC symptoms.

Key Points: 
  • Long COVID can cause new mental health symptoms, worsen existing mental health conditions, or mimic other LC symptoms.
  • Long COVID can cause new mental health symptoms and can also worsen existing mental health conditions or mimic other Long COVID symptoms.
  • "There really is some nuance in looking at the mental health symptoms of Long COVID because Long COVID symptoms that are related to mental health can also exacerbate or mimic other symptoms of Long COVID, such as fatigue, brain fog, and sleep disturbances," said Abby Cheng, MD, FAAPMR, author of the guidance.
  • Traditional nonpharmacologic and pharmacologic mental health treatments, such as SSRIs, should be considered in tandem for treating mental health symptoms of Long COVID.

Open Letter to ViewRay Customers, Service, Software Engineers and Suppliers—Let’s Preserve ViewRay Technology

Retrieved on: 
Wednesday, October 18, 2023

Suthanthiran has already received numerous inquiries from customers, vendors, and service engineers regarding this matter.

Key Points: 
  • Suthanthiran has already received numerous inquiries from customers, vendors, and service engineers regarding this matter.
  • He responds to all emails within 24 hours, so please do not hesitate to contact him with concerns and/or suggestions.
  • He wishes to remain in touch with all and feels that it is important that we act on this matter with urgency.
  • TBG and Suthanthiran are fully committed and hope that ultimately, this technology will be retained in the USA by USA manufacturers.

Relievant Medsystems Announces Pooled Analysis Demonstrating the Intracept Procedure Significantly Reduces Low Back Pain-related Healthcare Utilization

Retrieved on: 
Tuesday, September 12, 2023

The analysis was published in Pain Medicine , the official journal of the American Academy of Pain Medicine (AAPM).

Key Points: 
  • The analysis was published in Pain Medicine , the official journal of the American Academy of Pain Medicine (AAPM).
  • Through five years post-Intracept Procedure, patients with vertebrogenic pain experienced significant reductions in their need for opioids and therapeutic lumbosacral spine injections following treatment.
  • “Our previous findings validated basivertebral nerve ablation as an effective and durable treatment option for patients with vertebrogenic pain.
  • Individuals with moderate and high impact chronic low back pain had annual per person reported healthcare expenditures of $9,657 and $14,661, respectively.2
    Relievant Medsystems’ minimally invasive Intracept Procedure is the only FDA-cleared treatment for chronic vertebrogenic low back pain.

RaySearch to present the latest advances in RayStation, RayCare and RayIntelligence at AAPM 2023

Retrieved on: 
Monday, July 24, 2023

STOCKHOLM, July 23, 2023 /PRNewswire/ -- The latest version of RayStation includes among others support for automatic field-in-field planning for photons, a method that generates homogeneous and conformal dose distributions by combining a few subfields, as well as point-based optimization of brachy plans, and faster loading of data. Attendees will also be able to experience the next steps in workflow improvements for dosetracking and adaptive replanning. Within particle therapy planning, support for proton arcs and robust optimization based on linear energy transfer (LET) will be showed.

Key Points: 
  • RaySearch will be showcasing the latest software innovations at AAPM in Houston, Texas, July 23-27.
  • Attendees will be able to book demonstrations of RayStation®* treatment planning system, RayCare®* oncology information system, and the cloud-based oncology analytics system RayIntelligence® during the congress.
  • Attendees will also be able to experience the next steps in workflow improvements for dosetracking and adaptive replanning.
  • Within particle therapy planning, support for proton arcs and robust optimization based on linear energy transfer (LET) will be showed.

RefleXion Announces 28 Scientific Presentations at the AAPM 2023 Annual Meeting

Retrieved on: 
Thursday, July 20, 2023

RefleXion Medical , a therapeutic oncology company, today announced that researchers from multiple clinical programs will present new scientific evidence in 28 oral, panel, and poster presentations validating the efficacy and feasibility of the RefleXion® X1 machine with SCINTIX™ biology-guided radiotherapy at the 2023 American Association of Physicists in Medicine ( AAPM ) Annual Meeting in Houston, July 23-26.

Key Points: 
  • RefleXion Medical , a therapeutic oncology company, today announced that researchers from multiple clinical programs will present new scientific evidence in 28 oral, panel, and poster presentations validating the efficacy and feasibility of the RefleXion® X1 machine with SCINTIX™ biology-guided radiotherapy at the 2023 American Association of Physicists in Medicine ( AAPM ) Annual Meeting in Houston, July 23-26.
  • The company will also hold multi-target SCINTIX technology interactive demonstrations in booth #501.
  • Detailed information on all 28 presentations may be found here .
  • Overcoming the hurdles of targeting and motion management, especially for multiple tumors, is the core challenge in external-beam radiotherapy.

CIVCO Radiotherapy and Qfix Showcase as One Company at AAPM 2023

Retrieved on: 
Monday, July 17, 2023

CORALVILLE, Iowa, July 17, 2023 /PRNewswire/ -- CIVCO Radiotherapy and Qfix, now together as one company, will exhibit their innovative and patented solutions during the annual American Association of Physicists in Medicine (AAPM) 65th Annual Meeting in Houston, Texas, July 23-27, 2023.

Key Points: 
  • CORALVILLE, Iowa, July 17, 2023 /PRNewswire/ -- CIVCO Radiotherapy and Qfix, now together as one company, will exhibit their innovative and patented solutions during the annual American Association of Physicists in Medicine (AAPM) 65th Annual Meeting in Houston, Texas, July 23-27, 2023.
  • The company encourages attendees to visit booth #1411 to experience many of these solutions firsthand.
  • SBRT bridges, belts, and additional customization options are also available with the Alta™ Multipurpose Device (including Patient Transfer).
  • The Encompass™ and Solstice™ SRS Immobilization Systems are highly advanced, non-invasive solutions designed for precisely targeted brain, head, and neck treatments.

Neurological Long COVID Symptoms Guidance Statement Announced by the American Academy of Physical Medicine and Rehabilitation

Retrieved on: 
Tuesday, May 16, 2023

New data suggests antiviral treatments for COVID-19 may help prevent Long COVID, but millions of Americans still suffer from symptoms of Long COVID.

Key Points: 
  • New data suggests antiviral treatments for COVID-19 may help prevent Long COVID, but millions of Americans still suffer from symptoms of Long COVID.
  • "Identifying patients with progressive or ominous "red flag" neurological symptoms is essential for emergent triaging," said Dr. Leslie Rydberg, co-author of the neurology Long COVID guidance statement.
  • "These symptoms may be due to Long COVID versus another medical condition, but a history and physical examination is essential."
  • The American Academy of Physical Medicine and Rehabilitation is the national medical specialty organization representing more than 10,000 physicians specializing in physical medicine and rehabilitation.

Collegium Reports First Quarter 2023 Financial Results

Retrieved on: 
Thursday, May 4, 2023

ET –

Key Points: 
  • ET –
    STOUGHTON, Mass., May 04, 2023 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today reported its financial results for the quarter ended March 31, 2023, and provided a corporate update.
  • "We delivered record revenue and adjusted EBITDA in the first quarter driven by lower Xtampza ER gross-to-net, record Belbuca revenues and leveraging our fully synergized cost structure,” said Joe Ciaffoni, President and Chief Executive Officer of Collegium.
  • We are on track to achieve our strategic and financial objectives, and we are confident that 2023 will be a banner year.”
    “Our strong performance in the first quarter demonstrates our financial strength and discipline,” said Colleen Tupper, Chief Financial Officer of Collegium.
  • The Company reaffirms its full-year 2023 guidance for Product Revenues, Net, Adjusted Operating Expenses and Adjusted EBITDA: